127 related articles for article (PubMed ID: 26568839)
1. Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial.
Yuen DA; Kepecs DM; Zhang Y; Advani S; Thai K; Connelly KA; Gilbert RE
Can J Kidney Health Dis; 2015; 2():44. PubMed ID: 26568839
[TBL] [Abstract][Full Text] [Related]
2. Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.
Kepecs DM; Yuen DA; Zhang Y; Thai K; Connelly KA; Gilbert RE
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638853
[TBL] [Abstract][Full Text] [Related]
3. Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis.
Yuen DA; Connelly KA; Zhang Y; Advani SL; Thai K; Kabir G; Kepecs D; Spring C; Smith C; Batruch I; Kosanam H; Advani A; Diamandis E; Marsden PA; Gilbert RE
Stem Cells; 2013 Nov; 31(11):2408-19. PubMed ID: 23922321
[TBL] [Abstract][Full Text] [Related]
4. Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes.
Duarte DA; Papadimitriou A; Gilbert RE; Thai K; Zhang Y; Rosales MA; Lopes de Faria JB; Lopes de Faria JM
PLoS One; 2016; 11(2):e0147978. PubMed ID: 26836609
[TBL] [Abstract][Full Text] [Related]
5. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
6. Application of Modular Therapy for Renoprotection in Experimental Chronic Kidney Disease.
Kepecs DM; Zhang Y; Thai K; Advani SL; Yuen DA; Connelly KA; Kosanam H; Diamandis E; Sefton MV; Gilbert RE
Tissue Eng Part A; 2015 Jul; 21(13-14):1963-72. PubMed ID: 25661544
[TBL] [Abstract][Full Text] [Related]
7. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.
Yuen DA; Connelly KA; Advani A; Liao C; Kuliszewski MA; Trogadis J; Thai K; Advani SL; Zhang Y; Kelly DJ; Leong-Poi H; Keating A; Marsden PA; Stewart DJ; Gilbert RE
PLoS One; 2010 Mar; 5(3):e9543. PubMed ID: 20209052
[TBL] [Abstract][Full Text] [Related]
8. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
9. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.
van Koppen A; Joles JA; van Balkom BW; Lim SK; de Kleijn D; Giles RH; Verhaar MC
PLoS One; 2012; 7(6):e38746. PubMed ID: 22723882
[TBL] [Abstract][Full Text] [Related]
10. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
11. Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease.
van Koppen A; Joles JA; Bongartz LG; van den Brandt J; Reichardt HM; Goldschmeding R; Nguyen TQ; Verhaar MC
Cell Transplant; 2012; 21(10):2299-312. PubMed ID: 23231961
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
[TBL] [Abstract][Full Text] [Related]
16. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.
Yatsu T; Sanagi M; Fujimori A; Tomura Y; Hayashi K; Tanahashi M; Inagaki O
Pharmacol Res; 2003 Mar; 47(3):243-52. PubMed ID: 12591020
[TBL] [Abstract][Full Text] [Related]
17. D-penicillamine reduces renal injury in the remnant model of chronic renal failure in the rat.
Throssell D; Brown J; Furness PN; Rutty G; Walls J; Harris KP
Nephrol Dial Transplant; 1997 Jun; 12(6):1116-21. PubMed ID: 9198038
[TBL] [Abstract][Full Text] [Related]
18. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats.
Torras J; Cruzado JM; Riera M; Condom E; Duque N; Herrero I; Merlos M; Espinosa L; Lloberas N; Egido J; Grinyó JM
Kidney Int; 1999 Nov; 56(5):1798-808. PubMed ID: 10571788
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
